- Home
- WAFDP vs CINGW Comparison
WAFDP vs CINGW Comparison
Compare WAFDP & CINGW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAFDP
- CINGW
- Stock Information
- Founded
- WAFDP N/A
- CINGW N/A
- Country
- WAFDP United States
- CINGW United States
- Employees
- WAFDP 2208
- CINGW 13
- Industry
- WAFDP Major Banks
- CINGW Biotechnology: Pharmaceutical Preparations
- Sector
- WAFDP Finance
- CINGW Health Care
- Exchange
- WAFDP Nasdaq
- CINGW Nasdaq
- Market Cap
- WAFDP N/A
- CINGW N/A
- IPO Year
- WAFDP N/A
- CINGW 2021
- Fundamental
- Price
- WAFDP $16.93
- CINGW $0.08
- Analyst Decision
- WAFDP
- CINGW
- Analyst Count
- WAFDP 0
- CINGW 0
- Target Price
- WAFDP N/A
- CINGW N/A
- AVG Volume (30 Days)
- WAFDP N/A
- CINGW N/A
- Earning Date
- WAFDP N/A
- CINGW N/A
- Dividend Yield
- WAFDP N/A
- CINGW N/A
- EPS Growth
- WAFDP N/A
- CINGW N/A
- EPS
- WAFDP N/A
- CINGW N/A
- Revenue
- WAFDP N/A
- CINGW N/A
- Revenue This Year
- WAFDP N/A
- CINGW N/A
- Revenue Next Year
- WAFDP N/A
- CINGW N/A
- P/E Ratio
- WAFDP N/A
- CINGW N/A
- Revenue Growth
- WAFDP N/A
- CINGW N/A
- 52 Week Low
- WAFDP N/A
- CINGW N/A
- 52 Week High
- WAFDP N/A
- CINGW N/A
- Technical
- Relative Strength Index (RSI)
- WAFDP 43.65
- CINGW N/A
- Support Level
- WAFDP $16.21
- CINGW N/A
- Resistance Level
- WAFDP $17.52
- CINGW N/A
- Average True Range (ATR)
- WAFDP 0.39
- CINGW 0.00
- MACD
- WAFDP 0.01
- CINGW 0.00
- Stochastic Oscillator
- WAFDP 52.94
- CINGW 0.00
About WAFDP WaFd Inc. Depositary Shares
WaFd Inc is engaged in providing lending, depository, insurance, and other banking services to consumers, mid-sized to large businesses, and owners and developers of commercial real estate. Through the WaFd Bank, it is involved in accepting deposits from the general public and investing these funds in loans of various types, including first-lien mortgages on single-family dwellings, construction loans, land acquisition and development loans among others. The Bank also invests in certain United States government and agency obligations along with other investments and also performs insurance brokerage activities. Geographically, it operates in Washington, Oregon, Idaho, Arizona, Utah, Nevada, New Mexico, California and Texas.
About CINGW Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.